| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Hyong Kim is Chief Medical Officer at ALHC. From October 2023 to October 2026, the filings on record show 0 open-market purchases and 16 sales. Hyong Kim's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.2M at current prices.
Historically, Hyong Kim's trades have earned a middling insider score of 56/100 across 17 rated trades. Over a 12-month horizon, 38.5% of those trades were profitable, with an average 12-month return of -10.5%.
The ALHC filings lean toward selling, a net 431,272 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | ALHC Alignment Healthcare, Inc. | Chief Medical Officer | Sell | 8,266 | $16.40 | $135,570.55 | -1.5% | -15.2% | +5.6% | |
| Mar 7, 2025 | ALHC Alignment Healthcare, Inc. | Chief Medical Officer | Sell10b5-1 | 21,574 | $15.06 | $324,927.42 | -4.2% | -0.7% | +23.8% | |
| Mar 6, 2025 | ALHC Alignment Healthcare, Inc. | Chief Medical Officer | Sell | 21,020 | $15.65 | $328,970.73 | -4.0% | +0.5% | +20.9% | |
| Dec 5, 2024 | ALHC Alignment Healthcare, Inc. | Chief Medical Officer | Sell10b5-1 | 62,574 | $12.20 | $763,571.75 | -11.7% | +29.6% | +60.2% | |
| Oct 8, 2024 | ALHC Alignment Healthcare, Inc. | Chief Medical Officer | Sell | 22,460 | $11.03 | $247,733.80 | -4.0% | -3.4% | +50.9% | |
| Mar 19, 2024 | ALHC Alignment Healthcare, Inc. | Chief Medical Officer | Sell | 5,576 | $5.05 | $28,163.26 | -1.0% | +59.9% | +248.0% |